Auleon Biologicals
ABOUT Auleon
Company Profile
Chongqing Auleon Biologicals Co., Ltd. was established in 2007. The company is located in the national modern animal husbandry technology demonstration core area-Chongqing Rongchang District High-tech Industrial Development Zone. The company has a registered capital of 50 million yuan, covers an area of more than 100 mu, has a total investment of 0.2 billion yuan, and has total assets of 0.37 billion yuan. It is a modern GMP certification enterprise engaged in the research and development, production, sales and technical services of biological products for animals (pigs, cattle and sheep).
The company has built 5000 square meters of livestock products live vaccine workshop, including cell culture virus live vaccine production line, cell suspension culture virus live vaccine production line, swine fever live vaccine (rabbit source) production line, bacterial live vaccine (including bacterial culture subunit vaccine) production line, independent brucellosis live vaccine production line; 5500 square meters of livestock products inactivated vaccine workshop, including bacterial inactivated vaccine production line, cell culture virus inactivated vaccine production line, clostridium inactivated vaccine production line; 4500 square meters of quality inspection research and development center (including laboratories established according to P3 standard) and 1000 square meters of diagnostic products production workshop; 6000 square meters of pig, cow, sheep and rabbit experimental animal center; 5000 square meters of administrative office center; 2000 square meters of staff activity center, etc. The domestic advanced high-density bioreactor, suspension culture equipment, washing and drying linkage packaging line, freeze dryer and various inspection equipment have enabled Chongqing Aolong Biology to increase and grow year by year, with an annual production capacity of 1.5 billion. Have: sheep echinococcosis (hydatid) disease genetic engineering subunit vaccine (national class I new veterinary drug), brucellosis live vaccine (A19, S2), swine fever live vaccine, pseudorabies live vaccine, goat pox live vaccine, goat mycoplasma pneumonia inactivated vaccine, bovine Pasteuella mulocidocides inactivated vaccine and more than 20 kinds of products. Among them, the market share of sheep hydatid genetic engineering subunit vaccine, brucellosis S2 and other products ranks first in the country. Goat pox live vaccine products to deal with bovine nodular skin disease has a good therapeutic effect, products through foreign trade, foreign aid and other channels have been exported to Laos, Cambodia and other countries and regions., It has a very significant effect on the control of nodular skin diseases in local cattle.
The company has established close technical cooperation with the Royal New Zealand Academy of Sciences, Chinese Academy of Agricultural Sciences, China Agricultural University, China Veterinary Drug Supervision Institute, Sichuan Agricultural University, Southwest University, Lanzhou Animal Husbandry and Veterinary Research Institute, Harbin Veterinary Research Institute, Chongqing Academy of Animal Husbandry and other well-known universities and scientific research institutes. The annual R & D expenses account for about 10% of the current year's operating income, with more than 60 national patents. The company has now established a post-doctoral workstation and a Haizhi talent workstation. It has passed many certifications such as CNAS, GCP, integration of three standards, and integration of two technologies. It has won many honors such as Chongqing May 1 Labor Certificate, Chongqing 3A Harmonious Labor Relations Demonstration Enterprise, Chongqing Digital Workshop, Chongqing Intelligent Factory, Chongqing "Specialized and Special New" Enterprise, etc, it was rated as a national high-tech enterprise, Chongqing Enterprise Technology Center, Chongqing Technology Innovation Demonstration Enterprise, Chongqing Key Laboratory of Industry and Information Technology, etc. 2022 and 2023 have been awarded the title of "Top 50 Private Enterprises in Rongchang District" by Rongchang District Party Committee and District Government for two consecutive years, and won the honor of "Outstanding Enterprise in the 30th Anniversary of the Establishment of Rongchang National High-tech Zone.
The company adheres to the corporate goal of "biological high-tech to create the future, a hundred years of quality to create the dragon", and the corporate philosophy of "diligence will have, innovation can last long", with independent innovation, integrated innovation and technology introduction as the source of nuclear technology, Taking the needs of the country and society as its own responsibility, realizing the corporate purpose of "making well-known products for the benefit of mankind" and making positive contributions to the protection of my country's public health safety and the healthy development of animal husbandry.
Thank you for visiting the official website of Chongqing Auleon Biologicals. If you have cooperation intentions or suggestions, please contact us through the following methods, and we will give you feedback in time, thank you!
Marketing Center: +86-023-46761801
Technical Services: +86-023-46763511
HR: +86-023-46763267
International Trade: +86-023-46763211
Address: (No.5, 4th Branch Road) National High-tech Industrial Park, Rongchang District, Chongqing, China
© 2024 Chongqing Auleon Biologicals Co., Ltd. 
渝公网安备50022602000038号